Ivor MacLeod
Director of Finance/CFO at SCYNEXIS, INC.
Net worth: 235 495 $ as of 30/04/2024
Ivor MacLeod active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SCYNEXIS, INC. | Comptroller/Controller/Auditor | 24/10/2022 | - |
| Director of Finance/CFO | 24/10/2022 | - | |
| Public Communications Contact | 24/10/2022 | - |
Career history of Ivor MacLeod
Former positions of Ivor MacLeod
| Companies | Position | Start | End |
|---|---|---|---|
| ATHERSYS, INC. | Comptroller/Controller/Auditor | 19/05/2021 | 30/06/2022 |
| Director of Finance/CFO | 31/01/2020 | 30/06/2022 | |
| MERCK & CO., INC. | Director of Finance/CFO | - | - |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Compliance Officer | 01/06/2015 | - |
| Director of Finance/CFO | 01/06/2015 | - | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Chief Tech/Sci/R&D Officer | - | 05/04/2011 |
| Director of Finance/CFO | 05/04/2011 | - | |
| Corporate Officer/Principal | - | - |
Training of Ivor MacLeod
| Eller College of Management | Masters Business Admin |
| University of St. Andrews | Undergraduate Degree |
Statistics
International
| United States | 7 |
| United Kingdom | 2 |
Operational
| Director of Finance/CFO | 5 |
| Comptroller/Controller/Auditor | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| ATHERSYS, INC. | Health Technology |
| SCYNEXIS, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Private companies | 2 |
|---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
- Stock Market
- Insiders
- Ivor MacLeod
- Experience
